Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Clene Inc.
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity
February 13, 2023
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Nanomedicine Announces Participation in Renmark Virtual Non-Deal Roadshow Series on January 18 and January 23
January 11, 2023
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Nanomedicine Reports Topline Results of Phase 2 COVID-19 Study of CNM-ZnAg
December 27, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Announces Closing of $5 Million Debt Facility from the State of Maryland
December 12, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies
November 28, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights
November 07, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland
October 31, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial
October 03, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3
September 30, 2022
From
Clene Inc.
Via
GlobeNewswire
Tickers
CLNN
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today